ARRDC3 regulates the targeted therapy sensitivity of clear cell renal cell carcinoma by promoting AXL degradation
Article in Cell Cycle (January 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Cell Cycle (January 2024)
Article in Head and Neck Pathology (July 2023)
Preprint in Research Square (May 2023)